NewsRoom Articles - Page 82 of 208

TuesdayDec 27, 2022 10:30 am

Advisory Firm Appointment Underscores MetAlert, Inc. (MLRT) Strategy Amid Growth Stage and New Patient Location-tracking Technology Rollout

Pioneering GPS-enabled location device developer MetAlert is building on two decades of experience with new products designed to broaden its suite of technology for remote patient monitoring (“RPM”) in an unobtrusive manner plus monitoring seniors for falls MetAlert recently announced that it has engaged the financial strategy advisory firm Joseph Gunnar & Co., LLC to help direct its decisions ranging from acquisitions to potential up listing on a national exchange The company’s products include its flagship patented shoe insole device enabled with GPS, Bluetooth, and Wi-Fi functionality for tracking seniors or people with autism prone to wandering and getting lost,…

ThursdayDec 22, 2022 12:42 pm

Research Suggests That Vegetarian Diets Decrease Prostate Cancer Risk

Prostate cancer is the most common cancer in American men, affecting an estimated 3.2 million men in the country. While we don’t know exactly what causes prostate cancer, risk factors for the disease include age, family history, diet, obesity and ethnicity. Research has indicated that there may be some association between obesity and diet and the prevalence of prostate cancer. These past studies suggest that regular exercise and a balanced diet may help to reduce the risk of prostate cancer. Urologist Dr. Stephen Freedland, director of Cedars-Sinai Medical Center’s Center for Integrated Research in Cancer and Lifestyle, recently conducted a…

ThursdayDec 22, 2022 12:00 pm

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Updates of Recent Key Events and Plans for Calendar 2023; Announces Public Offering to Raise Funding for Operations

CNS Pharmaceuticals is a biopharmaceutical company that focuses on developing novel treatments for primary and metastatic cancers in the brain and central nervous system The company is currently evaluating the efficacy of Berubicin, a novel anthracycline that appears to cross the blood-brain barrier, in a potentially pivotal Phase 2 trial involving patients with recurrent glioblastoma multiforme (“GBM”) CEO John Climaco recently participated in the Virtual Investor “Ask the CEO” Event in which he provided an update on recent key events and plans for the future in addition to allaying the investors’ concerns regarding the recent reverse stock split CNS Pharmaceuticals…

WednesdayDec 21, 2022 10:55 am

Experts Push for More Studies into Link Between Asthma, Female Sex Hormones

Asthma is a common condition that causes an individual’s airways to swell and narrow, resulting in breathing difficulties, coughing and breathlessness. During childhood, the disease is more prevalent and severe in boys. Following puberty, however, asthma becomes more common and severe in women. Women have a heightened risk of developing this condition because female sex hormones can worsen symptoms of asthma, much like dust, pollen and air pollution does. The hormones may even trigger an asthma attack. It is common knowledge that women who have asthma are at risk of possibly fatal asthma attacks every month and experience worse symptoms…

WednesdayDec 21, 2022 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology

BEAT has developed technology that collects data to synthesize a 12-lead 3D vector electrocardiogram (“VECG”) The device provides physicians with a 12-lead ECG associated with chest pain compared to a baseline ECG for the patient This key data enables physicians to assess whether symptoms may be the result of a heart attack HeartBeam’s (NASDAQ: BEAT) small, portable, easy-to-use heart-attack detection solution was the focus of a recent Big Biz Show episode; the Big Biz Show features fast-talking, hard-hitting discussions on business and finance. During the interview, Big Biz Show host Bob “Sully” Sullivan chatted with HeartBeam founder and CEO Branislav…

TuesdayDec 20, 2022 12:13 pm

Research Finds Telehealth Patient Navigators Increase Appointment Attendance

New research has found that patient navigators increase attendance of video telehealth visits. Telehealth physician visits have significantly increased in number since the coronavirus pandemic. That adoption was encouraged in an effort to contain the spread of the virus. Despite this increase, technological challenges make it hard for some patients to keep their visits. For their 12-week pilot program, the investigators collected data from 4,066 patients who used video telehealth visits. Of the total number of patients, almost 63% were women. They divided the patients into two groups: the intervention group and the comparator group. The intervention group was made…

TuesdayDec 20, 2022 11:15 am

Jupiter Wellness Inc. (NASDAQ: JUPW) Issues Letter to Shareholders with Update on Key Corporate Milestones, Product Progress

Jupiter Wellness has announced that the “FDA of India” has approved its topical treatment for psoriasis and vitiligo, with a market launch to follow The global vitiligo treatment market was valued at $1.2 billion in 2018 and is expected to grow at a CAGR of 5.8%, resulting in a value of approximately $2 billion by 2026 JW-500, a topical treatment for female sexual wellness, is currently in development with plans to file for pre-IND and Orphan Drug Designation within the next year Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”)…

MondayDec 19, 2022 10:49 am

New Study Finds Localized Cooling of Brain Tumors Slows Growth in Mice Models

New research has found that cooling brain tumors improves rates of survival, which offers hope for new options for treatment for patients suffering from difficult brain cancers. The most common type of brain cancer, glioblastoma multiforme, is a fast-growing and aggressive cancer that usually occurs in an individual’s spinal cord or brain. While this particular type of cancer can develop at any age, it is more common in older adults. Surgery is usually the standard treatment for glioblastoma multiforme, followed by radiation and chemotherapy, as recommended by a patient’s oncologist. Despite these treatments, the rate of survival for this particular…

MondayDec 19, 2022 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection

BEAT continues impressive march forward in developing a suite of products designed to detect heart attacks anytime, anywhere Inventions protected by patent enable proprietary 3D vector ECG technology to be built into a smartwatch Projections for global smartwatch and wearables medical-device markets show consistent upward growth In a world where an estimated 202.6 million people use smartwatches (https://ibn.fm/zb66P), the ability to harness the power of smartwatches to help people live healthier lives can make a profound difference. That’s exactly what HeartBeam (NASDAQ: BEAT), a cardiac technology company with a track record for innovation and cutting-edge technology, hopes to do with…

FridayDec 16, 2022 12:45 pm

Trial Shows CAR-T Cells May Be Effective in Treating Brain, Spinal Cord Lymphoma

Lymphoma usually starts in the spinal cord or brain, although sometimes tumors can spread to these sites from other regions in the body. This cancer is usually difficult to treat, particularly once the tumors don’t respond to the standard treatments. In such cases, patients do not live longer than a couple of years. Investigators at Dana-Farber Cancer Institute have found that a new CAR-T cell therapy may be effective in the treatment of lymphoma of the brain and/or spinal cord. They discovered that the axi-cel (axicabtagene ciloleucel) therapy could be safely administered to patients with the above indication. They presented…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Advisory Firm Appointment Underscores MetAlert, Inc. (MLRT) Strategy Amid Growth Stage and New Patient Location-tracking Technology Rollout

Research Suggests That Vegetarian Diets Decrease Prostate Cancer Risk

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Provides Updates of Recent Key Events and Plans for Calendar 2023; Announces Public Offering to Raise Funding for Operations

Experts Push for More Studies into Link Between Asthma, Female Sex Hormones

HeartBeam Inc. (NASDAQ: BEAT) CEO Featured Guest on Big Biz Show, Talks ‘Breakthrough’ Heart-Attack Detection Technology

Research Finds Telehealth Patient Navigators Increase Appointment Attendance

Jupiter Wellness Inc. (NASDAQ: JUPW) Issues Letter to Shareholders with Update on Key Corporate Milestones, Product Progress

New Study Finds Localized Cooling of Brain Tumors Slows Growth in Mice Models

HeartBeam Inc. (NASDAQ: BEAT) Granted Patent for Proprietary ECG Smartwatch-Based Monitor Designed for Heart Attack Detection

Trial Shows CAR-T Cells May Be Effective in Treating Brain, Spinal Cord Lymphoma

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search